Caballero, Dhynn Aubrey .

HRN: 10-54-66  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/16/2022
CEFUROXIME 750MG (VIAL)
08/16/2022
08/22/2022
IVTT
185mg
Q8 X 7 Days
UTI
Waiting Final Action 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines

 Final appropriateness: Yes     

 Overall appropriateness: Yes